Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Moen SH"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rye TK; Department of Pharmacy, University of Oslo, Blindern, Norway., Lee CY; School of Life Sciences, Technical University of Munich, Freisng, Germany., Zellner A; School of Life Sciences, Technical University of Munich, Freisng, Germany., Moen SH; Department of Pharmacy, University of Oslo, Blindern, Norway., Dowlatshah S; Department of Pharmacy, University of Oslo, Blindern, Norway., Grønhaug Halvorsen T; Department of Pharmacy, University of Oslo, Blindern, Norway., Pedersen-Bjergaard S; Department of Pharmacy, University of Oslo, Blindern, Norway.; Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Hansen FA; Department of Pharmacy, University of Oslo, Blindern, Norway.
Publikováno v:
Journal of separation science [J Sep Sci] 2024 Aug; Vol. 47 (15), pp. e2400292.
Autor:
Nedal TMV; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Moen SH; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Research, Nord-Trøndelag Hospital Trust, Levanger, Norway., Roseth IA; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Tryggestad SS; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Aass KR; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Hov GG; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Clinical Chemistry, St. Olavs Hospital, Trondheim, Norway., Hella H; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Sponaas AM; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Standal T; Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. therese.standal@ntnu.no.; Department of Hematology, St. Olavs Hospital, Trondheim, Norway. therese.standal@ntnu.no.
Publikováno v:
Scientific reports [Sci Rep] 2024 Feb 13; Vol. 14 (1), pp. 3643. Date of Electronic Publication: 2024 Feb 13.
Autor:
Kohtala S; TrollLABS, Department of Mechanical and Industrial Engineering, Faculty of Engineering, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Nedal TMV; Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Kriesi C; TrollLABS, Department of Mechanical and Industrial Engineering, Faculty of Engineering, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Vitroscope AS, Trondheim, Norway., Moen SH; Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Ma Q; Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Ødegaard KS; Department of Mechanical and Industrial Engineering, Faculty of Engineering, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Standal T; Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Hematology, St. Olavs University Hospital, Trondheim, Norway., Steinert M; TrollLABS, Department of Mechanical and Industrial Engineering, Faculty of Engineering, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Publikováno v:
Frontiers in cell and developmental biology [Front Cell Dev Biol] 2022 Jul 05; Vol. 10, pp. 941542. Date of Electronic Publication: 2022 Jul 05 (Print Publication: 2022).
Autor:
Aass KR; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., Mjelle R; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., Kastnes MH; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., Tryggestad SS; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., van den Brink LM; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway., Aass Roseth I; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., Westhrin M; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway., Zahoor M; Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo 0372, Norway., Moen SH; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., Vikene Nedal TM; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., Buene G; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., Misund K; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., Sponaas AM; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., Ma Q; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., Sundan A; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway., Groen RW; Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam 1081, the Netherlands., Slørdahl TS; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Hematology, St.Olavs University Hospital, Trondheim 7491, Norway., Waage A; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Hematology, St.Olavs University Hospital, Trondheim 7491, Norway., Standal T; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway.; Department of Hematology, St.Olavs University Hospital, Trondheim 7491, Norway.
Publikováno v:
IScience [iScience] 2021 Dec 13; Vol. 25 (1), pp. 103605. Date of Electronic Publication: 2021 Dec 13 (Print Publication: 2022).
Autor:
Westhrin M; Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Kovcic V; Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Zhang Z; Department of Central Laboratory, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; and., Moen SH; Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Nedal TMV; Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Bondt A; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; and., Holst S; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; and., Misund K; Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Buene G; Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Sundan A; Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Waage A; Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Hematology, St. Olavs University Hospital, Trondheim, Norway., Slørdahl TS; Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Hematology, St. Olavs University Hospital, Trondheim, Norway., Wuhrer M; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands; and., Standal T; Centre of Molecular Inflammation Research (CEMIR), Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Hematology, St. Olavs University Hospital, Trondheim, Norway.
Publikováno v:
Blood [Blood] 2020 Dec 03; Vol. 136 (23), pp. 2656-2666.
Autor:
Yang R; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Elsaadi S; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Misund K; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Abdollahi P; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Vandsemb EN; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Moen SH; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Kusnierczyk A; PROMEC, Department for Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Slupphaug G; PROMEC, Department for Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Standal T; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; CEMIR (Centre of Molecular Inflammation Research), Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Waage A; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Hematology, St. Olavs Hospital, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Slørdahl TS; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Hematology, St. Olavs Hospital, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Rø TB; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Children's Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Rustad E; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Sundan A; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; CEMIR (Centre of Molecular Inflammation Research), Department of Clinical and Molecular Medicine, NTNU, Trondheim, Norway., Hay C; Oncology R&D, AstraZeneca Medimmune, Gaithersburg, Maryland, USA., Cooper Z; Oncology R&D, AstraZeneca Medimmune, Gaithersburg, Maryland, USA., Schuller AG; Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts, USA., Woessner R; Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts, USA., Borodovsky A; Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts, USA., Menu E; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel (VUB), Brussel, Massachusetts, Belgium., Børset M; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Sponaas AM; Center for Myeloma Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway anne-marit.sponaas@ntnu.no.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 May; Vol. 8 (1).
Autor:
Ehrnström B; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Infectious Diseases, Clinic of Medicine, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway., Kojen JF; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Giambelluca M; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Ryan L; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Moen SH; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Hu Z; Department of Chemistry and Biochemistry and BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA., Yin H; School of Pharmaceutical Sciences, Tsinghua University-Peking University Joint Center for Life Sciences, Tsinghua University, Beijing, China., Mollnes TE; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Research Laboratory, Nordland Hospital, and K. G. Jebsen TREC, University of Tromsø, Norway.; Department of Immunology, Oslo University Hospital and K. G. Jebsen IRC, University of Oslo, Oslo, Norway., Damås JK; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Infectious Diseases, Clinic of Medicine, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway., Espevik T; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Stenvik J; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Infectious Diseases, Clinic of Medicine, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway.
Publikováno v:
Journal of leukocyte biology [J Leukoc Biol] 2020 Apr; Vol. 107 (4), pp. 673-683. Date of Electronic Publication: 2020 Feb 21.
Autor:
Westhrin M; Department of Clinical and Molecular Medicine, Faculty of Medicine Norwegian University of Science and Technology (NTNU) Trondheim Norway.; Centre of Molecular Inflammation Research (CEMIR) Norwegian University of Science and Technology Trondheim Norway., Holien T; Department of Clinical and Molecular Medicine, Faculty of Medicine Norwegian University of Science and Technology (NTNU) Trondheim Norway.; Department of Hematology St. Olavs Hospital Trondheim Norway., Zahoor M; Centre of Molecular Inflammation Research (CEMIR) Norwegian University of Science and Technology Trondheim Norway., Moen SH; Department of Clinical and Molecular Medicine, Faculty of Medicine Norwegian University of Science and Technology (NTNU) Trondheim Norway.; Centre of Molecular Inflammation Research (CEMIR) Norwegian University of Science and Technology Trondheim Norway., Buene G; Department of Clinical and Molecular Medicine, Faculty of Medicine Norwegian University of Science and Technology (NTNU) Trondheim Norway.; Centre of Molecular Inflammation Research (CEMIR) Norwegian University of Science and Technology Trondheim Norway., Størdal B; Department of Clinical and Molecular Medicine, Faculty of Medicine Norwegian University of Science and Technology (NTNU) Trondheim Norway., Hella H; Department of Clinical and Molecular Medicine, Faculty of Medicine Norwegian University of Science and Technology (NTNU) Trondheim Norway., Yuan H; Kuros Biosciences BV Bilthoven The Netherlands., de Bruijn JD; Kuros Biosciences BV Bilthoven The Netherlands.; The School of Engineering and Materials Science Queen Mary University of London London UK., Martens A; Department of Hematology Cancer Center Amsterdam, VU University Medical Center Amsterdam The Netherlands., Groen RW; Department of Hematology Cancer Center Amsterdam, VU University Medical Center Amsterdam The Netherlands., Bosch F; Center of Animal Biotechnology and Gene Therapy and Department of Biochemistry and Molecular Biology School of Veterinary Medicine, Universitat Autònoma de Barcelona Barcelona Spain.; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM) Madrid Spain., Smith U; Department of Molecular and Clinical Medicine Sahlgrenska University Hospital Gothenburg Sweden., Sponaas AM; Department of Clinical and Molecular Medicine, Faculty of Medicine Norwegian University of Science and Technology (NTNU) Trondheim Norway., Sundan A; Department of Clinical and Molecular Medicine, Faculty of Medicine Norwegian University of Science and Technology (NTNU) Trondheim Norway.; Centre of Molecular Inflammation Research (CEMIR) Norwegian University of Science and Technology Trondheim Norway., Standal T; Department of Clinical and Molecular Medicine, Faculty of Medicine Norwegian University of Science and Technology (NTNU) Trondheim Norway.; Centre of Molecular Inflammation Research (CEMIR) Norwegian University of Science and Technology Trondheim Norway.; Department of Hematology St. Olavs Hospital Trondheim Norway.
Publikováno v:
JBMR plus [JBMR Plus] 2019 Nov 22; Vol. 4 (1), pp. e10247. Date of Electronic Publication: 2019 Nov 22 (Print Publication: 2020).
Autor:
Moen SH; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Ehrnström B; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Infectious Diseases, Clinic of Medicine, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway., Kojen JF; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Yurchenko M; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Beckwith KS; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Afset JE; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Clinic of Laboratory Medicine, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway., Damås JK; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Infectious Diseases, Clinic of Medicine, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway., Hu Z; Department of Chemistry and Biochemistry and BioFrontiers Institute, University of Colorado Boulder, Boulder, CO, United States., Yin H; School of Pharmaceutical Sciences, Tsinghua University-Peking University Joint Center for Life Sciences, Beijing Advanced Innovation Center for Structural Biology, Tsinghua University, Beijing, China., Espevik T; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Stenvik J; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Infectious Diseases, Clinic of Medicine, St. Olavs Hospital HF, Trondheim University Hospital, Trondheim, Norway.
Publikováno v:
Frontiers in immunology [Front Immunol] 2019 May 31; Vol. 10, pp. 1209. Date of Electronic Publication: 2019 May 31 (Print Publication: 2019).